Pulmonary Hypertension - New Trends of Diagnostic and Therapy
Authors:
- Zijo BegicZBZijo Begic
- Nihad KukavicaNKNihad Kukavica
- Edin BegicEBEdin Begic
- Nihad BegicNBNihad Begic
Open Access
- 1 January 2016
- journal article
- review article
- Published by ScopeMed in Medical Archives
- Vol. 70 (4) , 303-307
Abstract
Pulmonary hypertension is a pathophysiological state hemodynamically defined as the increase of the mean pulmonary arterial pressure above 25, or 30 mmHg at rest, measured by catheterization of the right heart. Laboratory findings usually reveals polycythemia, the ECG right ventricle hypertrophy, and x-ray characteristic of diseased branches (echocardiography and biomarkers such as B-type natriuretic peptide (BNP) and N-terminal pro-BNP hormones are potentially helpful tools in identifying PH). Echocardiography can be found the increase of the right atrium and ventricle, right ventricular hypertrophy, abnormal contraction of the interventricular septum, left ventricular diastolic dysfunction and decreased left ventricular size, with reduced volumes of systole and end diastole. Doppler confirming tricuspid regurgitation. Pharmacological therapy would represent a use: Calcium Channel Blockers, Prostacyclin Analogues, Endothelin Receptor Antagonists and Phosphodiesterase-5 Inhibitors. Alpha adrenergic antagonists, endothelial receptor subtype A (Bosentan, Tracller) with treatment of the underlying disease or anticongestive therapy, are recommended. In case of inadequate response to treatment with a specific drug, guidelines recommend the combined use of drugs from the basic three groups, using their synergism.Keywords
This publication has 17 references indexed in Scilit:
- 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertensionEuropean Heart Journal, 2015
- Causes of Pulmonary Hypertension in the ElderlyChest, 2014
- The Changing Picture of Patients With Pulmonary Arterial Hypertension in the United StatesChest, 2011
- Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)European Heart Journal, 2009
- Diagnosis and Assessment of Pulmonary Arterial HypertensionJACC, 2009
- Pulmonary hypertension: diagnosis and management.2009
- Pulmonary hypertension in interstitial lung disease: Fig. 1—European Respiratory Journal, 2008
- An epidemiological study of pulmonary arterial hypertensionEuropean Respiratory Journal, 2007
- High Frequency of BMPR2 Exonic Deletions/Duplications in Familial Pulmonary Arterial HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2006
- BMPR2 gene rearrangements account for a significant proportion of mutations in familial and idiopathic pulmonary arterial hypertensionHuman Mutation, 2006